Our technology spans the patient journey to streamline processes and connect physicians, no matter where they are.
Breast cancer awareness is essential, but awareness alone isn’t enough—early detection through imaging and efficient screening workflows are critical to reducing mortality and improving outcomes.
Raising awareness is important, but it must be paired with action. Screening mammography is considered the best method for reducing breast cancer deaths through early detection. Without timely imaging, awareness cannot translate into prevention, diagnosis, or treatment.
Yes, mortality rates have declined steadily for decades in the U.S. However, experts warn this trend could reverse due to screening disruptions during COVID-19. A JAMA Oncology study found 3.9 million fewer screenings occurred between March–May 2020 compared to the same period in 2019.
Screening mammography is the most effective way to reduce breast cancer deaths. Delays in screening increase the risk of late-stage diagnoses. Despite recovery efforts, mammography remains underutilized, raising concerns about long-term outcomes.
To address pent-up demand, Intelerad offers advanced breast imaging solutions, including PenRad Technologies’ mammography information system.
These tools:
Visit Intelerad at RSNA 2023 to explore how our solutions help radiologists, technologists, and administrators improve productivity and patient care.
EHR strategies fall short when imaging lives outside clinical workflows. True imaging integration embeds images directly into the EHR - eliminating context-switching, reducing duplicate exams, and enabling faster, more confident decisions across the enterprise.
Radiology groups expand coverage across multiple facilities by enabling friction-free remote reading through unified cloud solutions that eliminate the complexity of managing disparate hospital systems.
Remote reading has become essential to enterprise imaging operations because healthcare organizations need scalable, flexible solutions to address critical workforce shortages, fluctuating imaging volumes, and 24/7 subspecialty coverage demands.